Myles Wolf

Myles Wolf

Directeur/Membre du Conseil chez AKEBIA THERAPEUTICS, INC.

Fortune : 192 752 $ au 30/06/2026

55 ans
Consumer Services
Health Technology

Profil

Myles Wolf currently works at Weill Cornell Medicine, as Chairman-Medicine, World Kidney Fund - International Society of Nephrology, as Chairman-North American Region, Akebia Therapeutics, Inc., as Independent Director from 2020, and Duke University School of Medicine, as Professor.
Dr. Wolf received his undergraduate degree from The Johns Hopkins University, graduate degree from Harvard Medical School, and doctorate degree from The State University of New York.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
17/06/2026 169 081 ( 0,06 % ) 192 752 $ 30/06/2026

Postes actifs de Myles Wolf

SociétésPosteDébut
AKEBIA THERAPEUTICS, INC. Directeur/Membre du Conseil 06/04/2020
Corporate Officer/Principal 01/01/2002
The International Society of Nephrology (Belgium)
Corporate Officer/Principal -
Corporate Officer/Principal -

Formation de Myles Wolf

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

17

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Consumer Services

Consumer Services

Health Technology

Consumer Services

Consumer Services

The International Society of Nephrology (Belgium)

Consumer Services

  1. Bourse
  2. Insiders
  3. Myles Wolf
🔇